BioNTech SE (BNTX) Misses Q1 EPS by 18c

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.31), EUR0.18 worse than the analyst estimate of (EUR1.13). Revenue for the quarter came in at EUR187.6 million versus the consensus estimate of EUR305 million.

BioNTech still expects group revenues for the full 2024 financial year to be in the range of €2.5 billion to €3.1 billion

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• MP Materials seen largely insulated after China export-control move